HALEON UK TRADING LIMITED

Active
Company number 09237643Private limited companyIncorporated 2014

Key figures

£554,826,000+8.3%
Net assets 2024
+8.3%
Average annual growth 2023–2024
0200 m400 m600 m20232024

† HALEON UK TRADING LIMITED filed these accounts on paper, so Companies House publishes them only as a scanned image. The figures for the years marked † were read automatically from the scan and kept only where the statements add up (for example net assets equal total equity), but a reading error is still possible — check the original accounts at Companies House.

Ratios

2024

Sector comparison

SIC 46460

Where the company stands among the 2,974 active companies whose first SIC code is 46460 (Wholesale of pharmaceutical goods).

Turnover£1,106,893,000
Higher than 96% · median £23,764,000 among 214 that publish turnover
Net assets£554,826,000
Higher than 99% · median £32,520
Total assets£989,956,000
Higher than 99% · median £255,000
Cash£4,905,000
Higher than 94% · median £90,159
Employees1,474
Higher than 99% · median 1
Company age12.1 years
Older than 69% · median 6.2 years
Largest in this sector by net assets
  1. CSL BEHRING HOLDINGS LIMITED£11bn
  2. VIIV HEALTHCARE UK LIMITED£5.7bn
  3. MCKESSON GLOBAL SOURCING LIMITED£1bn
  4. MCKESSON MEDICAL-SURGICAL SOURCING LIMITED£999.5m
  5. PFIZER LIMITED£984m
  6. ABBOTT LABORATORIES LIMITED£871.8m
  7. GLAXOSMITHKLINE UK LIMITED£779m
  8. UNIKERIS LIMITED£642m
  9. HALEON UK TRADING LIMITED£554.8m
  10. MUNDIPHARMA MEDICAL COMPANY LIMITED£461.7m

Positions are approximate. Figures come from each company's latest accounts; money and employee figures are compared only with companies that filed accounts in pounds for a period ending in the last two and a half years and are not dormant, so those groups are smaller than 2,974. The line on each bar marks the median.

Summary: HALEON UK TRADING LIMITED

What kind of company is it?

HALEON UK TRADING LIMITED is a private limited company registered with Companies House under company number 09237643. It was incorporated on 26 Sep 2014. Its status is active. The registered office is in Weybridge (KT13). Its nature of business (SIC 2007) is wholesale of pharmaceutical goods (46460).

How is the company doing financially?

The latest accounts in the database are for 2024 (period ending 31 Dec 2024); the company files full accounts. Turnover was £1,106,893,000. Profit for the year was £28,136,000. Net assets were £554,826,000, up 8.3% on the previous year. Cash at bank and in hand was £4,905,000. Total assets were £989,956,000 and total liabilities £435,130,000. The company had an average of 1,474 employees. Figures are available for 2 financial years (2023–2024).

How does it compare with similar companies?

Compared with 2,974 active companies whose first SIC code is 46460: By turnover it ranks higher than 96% of the 214 that publish turnover (median £23,764,000). By net assets it ranks higher than 99% of them (median £32,520). By total assets it ranks higher than 99% of them (median £255,000). By cash it ranks higher than 94% of them (median £90,159). By number of employees it ranks higher than 99% of them (median 1). It is older than 69% of them (median age 6.2 years).

Has it received government grants?

It is recorded as the recipient of one central government grant worth £1,396, from Department for Business, Energy and Industrial Strategy.

What do public registers and reports show?

HMRC lists it as an importer of goods, mainly perfumery and cosmetics, machinery, organic chemicals. HMRC lists it as an exporter of goods, mainly perfumery and cosmetics, inorganic chemicals, plastics. In its latest payment practices report it took an average of 82 days to pay suppliers, and 5% of invoices were not paid within agreed terms. Its gender pay gap report for 2025/26 shows median hourly pay for women 2.7% lower than for men. It has modern slavery statements on the government registry for 6 years.

Who runs and controls the company?

One person with significant control is registered.

When are its next filings due?

The next accounts are due by 31 Dec 2026. The next confirmation statement is due by 25 Sep 2027.

Filed accounts2023–2024
2023 †2024 †
Turnover1,077,452,0001,106,893,000
Profit for the year39,878,00028,136,000
Cash at bank and in hand4,930,0004,905,000
Total assets886,288,000989,956,000
Total liabilities373,747,000435,130,000
Net assets / total equity512,541,000554,826,000
Average number of employees1,4311,474

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Government grants

1 grant

HALEON UK TRADING LIMITED is recorded as the recipient of 1 central government grant, worth £1,396.

Grant
  1. University of Southampton and Glaxosmithkline Consumer Healthcare (UK) Trading LimitedDepartment for Business, Energy and Industrial Strategy · £1,396 · UKRI - Innovate UK - Scheme 22/23

From the Government Grants Register published by the Cabinet Office (financial years 2016/17 onwards, Open Government Licence v3.0). It covers grants from central government departments and their agencies where the register states the recipient's company number and the recipient name matches this company; grants from local authorities, lottery distributors and devolved governments are not included.

Statutory reporting

Payment practices1 Jan 2026 – 30 Jun 2026
Average time taken to pay invoices
82 days
Invoices not paid within agreed terms
5%
Standard payment terms
0–120 days
Member of a payment code
No
  • Within 30 days 8%
  • 31 to 60 days 8%
  • After 60 days 84%
Earlier periods (7)
Period ending
Days to pay
Within 30 days
Late
31 Dec 2025
78
10%
2%
30 Jun 2025
68
16%
4%
31 Dec 2024
61
16%
4%
30 Jun 2024
54
19%
5%
31 Dec 2023
52
18%
4%
30 Jun 2023
54
18%
6%
31 Dec 2022
67
16%
12%

View the latest report on GOV.UK

Gender pay gap2025/26
Median hourly pay
women 2.7% lower
Mean hourly pay
women 1.2% lower
Median bonus pay
women 4.9% lower
Employer size
1000 to 4999 employees
Lower pay quarter46% womenLower middle58% womenUpper middle53% womenUpper pay quarter46% women
Earlier years (8)
Year
Median hourly pay
Mean hourly pay
2024/25
women 3.5% lower
women 3.3% lower
2023/24
women 4.5% lower
women 4.4% lower
2022/23
women 4.7% lower
women 5.1% lower
2021/22
women 7.2% higher
women 2.5% lower
2020/21
women 9.4% higher
women 1.2% lower
2019/20
women 13.7% higher
women 2.8% higher
2018/19
women 16.6% higher
women 1.6% higher
2017/18
women 17.1% higher
women 4.5% higher

A positive gap means women's average hourly pay is lower than men's across the whole employer; it is not a comparison of pay for the same work. View on the Gender pay gap service

Modern slavery statements6
2026
Statement · summary on GOV.UK · group statement (HALEON PLC)
2025
Statement · summary on GOV.UK · group statement (HALEON PLC)
2024
Statement · summary on GOV.UK · group statement (HALEON PLC)
Earlier years (3)
2023
Statement · summary on GOV.UK · group statement (HALEON PLC)
2022
Statement · summary on GOV.UK · group statement (GSK PLC)
2021
Statement · summary on GOV.UK · group statement (GSK PLC)

Figures the company reported itself to the government's Check payment practices service, Gender pay gap service and Modern slavery statement registry (Open Government Licence v3.0). Only large companies and employers with 250 or more staff have to report, so most companies have nothing here.

Registers and licences

International trade‡

Listed by HMRC as an importer of goods in 11 of the last 12 months on record, most recently August 2026. Main goods: perfumery and cosmetics, machinery, organic chemicals, plastics and electrical equipment.

Listed by HMRC as an exporter of goods in 10 of the last 12 months on record, most recently August 2026. Main goods: perfumery and cosmetics, inorganic chemicals, plastics, clocks and watches and miscellaneous manufactures.

From HMRC's monthly lists of importers and exporters. Traders can ask to be left off the lists, so absence does not mean a company does not trade.

Sources: Charity Commission for England and Wales, Care Quality Commission, Home Office and HM Revenue & Customs, under the Open Government Licence v3.0. Entries marked ‡ come from lists that do not state a company number and were linked by an exact match on the registered name.

History

13 events
  1. Financial year 2024 endedAccounts: turnover £1.1bn, net assets £554.8m, 1,474 employees
  2. Financial year 2023 endedAccounts: turnover £1.1bn, net assets £512.5m, 1,431 employees
  3. Name changed to HALEON UK TRADING LIMITEDPreviously GLAXOSMITHKLINE CONSUMER HEALTHCARE (UK) TRADING LIMITED
  4. Haleon Uk Holdings (No.3) Limited registered as a person with significant control
  5. Gsk Consumer Healthcare Holdings (No.5) Limited ceased to be a person with significant control
  6. Gsk Consumer Healthcare Holdings (No.5) Limited registered as a person with significant control
  7. Prism Pch Limited ceased to be a person with significant control
  8. Prism Pch Limited registered as a person with significant control
Earlier events (5)
  1. Consumer Healthcare Holdings Limited ceased to be a person with significant control
  2. Consumer Healthcare Holdings Limited registered as a person with significant control
  3. Glaxosmithkline Consumer Healthcare Holdings Limited ceased to be a person with significant control
  4. Glaxosmithkline Consumer Healthcare Holdings Limited registered as a person with significant control
  5. Company incorporatedPrivate limited company

Dates as recorded at Companies House: incorporation, name changes, officer appointments and resignations, current and former persons with significant control, and the end of each financial year with figures in the database.